These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20416070)

  • 1. The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.
    Paglialunga S; Fisette A; Munkonda M; Gao Y; Richard D; Cianflone K
    BMC Physiol; 2010 Apr; 10():4. PubMed ID: 20416070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.
    Cui W; Paglialunga S; Kalant D; Lu H; Roy C; Laplante M; Deshaies Y; Cianflone K
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1482-91. PubMed ID: 17711993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms.
    Munkonda MN; Lapointe M; Miegueu P; Roy C; Gauvreau D; Richard D; Cianflone K
    PLoS One; 2012; 7(10):e46883. PubMed ID: 23056509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein.
    Murray I; Havel PJ; Sniderman AD; Cianflone K
    Endocrinology; 2000 Mar; 141(3):1041-9. PubMed ID: 10698180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice.
    Paglialunga S; Schrauwen P; Roy C; Moonen-Kornips E; Lu H; Hesselink MK; Deshaies Y; Richard D; Cianflone K
    J Endocrinol; 2007 Aug; 194(2):293-304. PubMed ID: 17641279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet.
    Roy C; Paglialunga S; Fisette A; Schrauwen P; Moonen-Kornips E; St-Onge J; Hesselink MK; Richard D; Joanisse DR; Cianflone K
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1051-9. PubMed ID: 18398012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential chemoattractant response in adipocytes and macrophages to the action of acylation stimulating protein.
    Tom FQ; Gauvreau D; Lapointe M; Lu H; Poursharifi P; Luo XP; Cianflone K
    Eur J Cell Biol; 2013 Feb; 92(2):61-9. PubMed ID: 23245988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M; Aust L; Frenz U; Noack R
    Ann Nutr Metab; 1996; 40(1):10-23. PubMed ID: 8722302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice.
    Xia Z; Stanhope KL; Digitale E; Simion OM; Chen L; Havel P; Cianflone K
    J Biol Chem; 2004 Feb; 279(6):4051-7. PubMed ID: 14615480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of metabolic drugs on the secretion of acylation stimulating protein in 3T3-L1 adipocytes].
    Gao Y; Cianflone K; Gauvreau D; Cui W; Ma YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1051-4. PubMed ID: 23046937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes.
    Gao Y; Gauvreau D; Cianflone K
    J Cell Biochem; 2010 Apr; 109(5):896-905. PubMed ID: 20069551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat.
    Rustan AC; Hustvedt BE; Drevon CA
    J Lipid Res; 1993 Aug; 34(8):1299-309. PubMed ID: 8409764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.
    Havel PJ
    Curr Opin Lipidol; 2002 Feb; 13(1):51-9. PubMed ID: 11790963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chylomicron effect on ASP production in 3T3-L1 adipocytes.
    Gao Y; Gauvreau D; Cui W; Lapointe M; Paglialunga S; Cianflone K
    Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):154-9. PubMed ID: 21266544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.
    Cui W; Lapointe M; Gauvreau D; Kalant D; Cianflone K
    Mol Immunol; 2009 Oct; 46(16):3207-17. PubMed ID: 19767107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin.
    Murray I; Parker RA; Kirchgessner TG; Tran J; Zhang ZJ; Westerlund J; Cianflone K
    J Lipid Res; 1997 Dec; 38(12):2492-501. PubMed ID: 9458273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.
    Herling AW; Kilp S; Elvert R; Haschke G; Kramer W
    Endocrinology; 2008 May; 149(5):2557-66. PubMed ID: 18276749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in plasma acylation stimulating protein during euglycaemic-hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study.
    St-Pierre DH; Cianflone K; Smith J; Coderre L; Karelis AD; Imbeault P; Lavoie JM; Rabasa-Lhoret R
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):539-46. PubMed ID: 18702682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice.
    Fisette A; Munkonda MN; Oikonomopoulou K; Paglialunga S; Lambris JD; Cianflone K
    Immunobiology; 2013 Jan; 218(1):127-33. PubMed ID: 22622332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise in transgenic mice overexpressing GLUT4 glucose transporters: effects on substrate metabolism and glycogen regulation.
    Bao S; Garvey WT
    Metabolism; 1997 Nov; 46(11):1349-57. PubMed ID: 9361698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.